搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
BioPharma Dive
1 小时
Tune raises $175M for hepatitis B medicine, epigenetic research
The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...
BioPharma Dive
2 天
CBD Care Skin Cream: Reviews, Advantages, Price!
Jan. 11, 2025 – Jan. 23, 2025 • New york, New York ...
BioPharma Dive
2 天
Golden Revive Plus[IS FAKE or REAL?] Read About 100% Natural Product?
Jan. 18, 2025 – Jan. 31, 2025 • https://www.facebook.com/GetGoldenRevivePlus/, India ...
BioPharma Dive
2 天
Golden Revive Plus:Serious Side Effects or Safe Ingredients? (MAJOR January 2025 Update)
Jan. 11, 2025 – Jan. 31, 2025 • new york, New York ...
BioPharma Dive
2 天
Lipozem Reviews: A Word Of Caution from An Honest Analytical Expert, Customer Experiences ...
Jan. 11, 2025 – Aug. 22, 2025 • New York, New York ...
BioPharma Dive
2 天
Jessica Johnson Joins ON Partners, Elevating Expertise in Healthcare and Life Sciences
She joins a team of experts at ON Partners, including partners Nina McMaster and Suzanne Zebedee, Ph.D., both recognized for ...
BioPharma Dive
2 天
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
BioPharma Dive
2 天
MITOLYN Reviews — [Updated 2025] Should Retail Should You Try It
Jan. 10, 2025 – Jan. 31, 2025 • New York, NY, USA, New York ...
BioPharma Dive
3 天
Pfizer’s PD-1 drug succeeds; AbbVie writes down $3.5B in Cerevel assets
Sasanlimab, a subcutaneous immunotherapy developed by Pfizer, could help treat bladder cancer. Elsewhere, Royalty Pharma ...
BioPharma Dive
3 天
Ouro, backed by GSK, joins hunt to bring bispecifics to autoimmune disease
Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈